Therapeutic substituted chlorocyclopentanols

Details for Australian Patent Application No. 2011207352 (hide)

Owner Allergan, Inc.

Inventors Old, David W.; Ngo, Vinh X.

Agent Davies Collison Cave

Pub. Number AU-A-2011207352

PCT Pub. Number WO2011/091276

Priority 12/692,368 22.01.10 US

Filing date 21 January 2011

Wipo publication date 28 July 2011

International Classifications

C07D 333/16 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/381 - having five-membered rings

A61P 27/02 Drugs for disorders of the senses

A61P 27/06 Drugs for disorders of the senses

C07D 333/38 Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 409/08 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/091276 Priority application(s): WO2011/091276

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011207355-Targeted heterologous antigen presentation on Calicivirus virus-like particles

2011207349-Hydraulic device including a spool valve and method of use thereof